Feb 03, 2021 / 01:00PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Veracyte's conference call regarding its agreement to acquire Decipher Biosciences. As a reminder, today's conference call is being recorded. I'd now like to hand the conference over to Tracy Morris, Veracyte's Vice President of Corporate Communications and Investor Relations. You may begin.
Tracy Morris - Veracyte, Inc. - VP of Corporate Communications & IR
Thank you, Ashley. Good morning, everyone, and thanks for joining us today for a discussion of our agreement to acquire Decipher Biosciences, which we announced earlier this morning. We expect to close the acquisition by May 2021, subject to regulatory approval and the satisfaction of other customary conditions. In conjunction with today's announcement, Veracyte announced our preliminary financial results for the fourth quarter and full year ended December 31, 2020. This information may be found on our website. With me today are Bonnie Anderson, Veracyte's Chairman and Chief Executive Officer; Keith Kennedy, our Chief Operating Officer and Chief Financial
Veracyte Inc To Acquire Decipher Biosciences Call Transcript
Feb 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers